Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00050570 · ClinicalTrials.gov registry record · NA

Reducing Eating Disorder Risk Factors

A NA study, sponsored by Stanford University.

Completed
Registry status
NA
Development phase
206
Enrollment target

NCT00050570: Completed NA study, sponsored by Stanford University.

NCT00050570 is a NA study that has completed, run by Stanford University. The registered enrollment target is 206 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (85% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT00050570, a NA study, has completed, sponsored by Stanford University.

COMPLETED
Registry status
NA
Development phase
206 participants
Enrollment target

Study Summary

The purpose of this study is to determine whether a web-based program is effective in reducing the incidence of eating disorders in college women who are at high risk for developing an eating disorder.

Primary Outcome

The main outcome is the onset of an eating disorder, as defined by DSM-IV

Interventions

  • BEHAVIORAL Web-based intervention to reduce eating disorder risk factors

Trial Details

FieldValue
Enrollment Target 206 participants
Start Date 2001-02
Est. Completion 2012-04-30
Phase NA
Stanford University

1,744 total trials

What the finished NCT00050570 record still lists

NCT00050570 is an interventional study that assigns participants to a tested intervention. The registered 206 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (85% lower).

The record links to 0 conditions, and to 1 intervention - of which Web-based intervention to reduce eating disorder risk factors is the first listed.

NCT00050570 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00050570 about?

NCT00050570 is a clinical study titled "Reducing Eating Disorder Risk Factors". The purpose of this study is to determine whether a web-based program is effective in reducing the incidence of eating disorders in college women who are at high risk for developing an eating disorder.

What is the current status of trial NCT00050570?

This trial is currently completed. It is a NA study. The enrollment target is 206 participants. The study started on 2001-02. Estimated completion is 2012-04-30.

What interventions are being tested in trial NCT00050570?

The interventions under investigation include: Web-based intervention to reduce eating disorder risk factors (BEHAVIORAL).

Who is sponsoring clinical trial NCT00050570?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00050570's enrollment target sits among peer trials

206 499th of 2000 higher than 1,502 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03373968 · 206 participants · Phase 2

    Givinostat in Duchenne's Muscular Dystrophy Long-term Safety and Tolerability Study

  • NCT03550391 · 206 participants · Phase 3

    Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5 or More Brain Metastases

  • NCT04757116 · 206 participants · NA

    Post-Market Study to Assess iTind Safety in Comparison to UroLift

  • NCT05675865 · 206 participants · NA

    Cryoablation for Monomorphic Ventricular Tachycardia

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00050570, the US trial registry maintained by the National Library of Medicine. NCT00050570 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.